Anke Wahlers

1.1k total citations · 1 hit paper
9 papers, 880 citations indexed

About

Anke Wahlers is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Anke Wahlers has authored 9 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Oncology. Recurrent topics in Anke Wahlers's work include Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and RNA Interference and Gene Delivery (5 papers). Anke Wahlers is often cited by papers focused on Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and RNA Interference and Gene Delivery (5 papers). Anke Wahlers collaborates with scholars based in Germany, France and Japan. Anke Wahlers's co-authors include Boris Fehse, Klaus Kühlcke, Christopher Baum, Wolfram Ostertag, Johann Meyer, Zhixiong Li, Bernd Schiedlmeier, Oliver Frank, Manfred Schmidt and Hans‐Georg Eckert and has published in prestigious journals such as Science, Blood and Journal of Virology.

In The Last Decade

Anke Wahlers

8 papers receiving 844 citations

Hit Papers

Murine Leukemia Induced by Retroviral Gene Marking 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Wahlers Germany 8 630 579 297 104 77 9 880
Bernd Schiedlmeier Germany 7 555 0.9× 506 0.9× 212 0.7× 67 0.6× 110 1.4× 8 749
Daniela Sartori Italy 11 900 1.4× 760 1.3× 310 1.0× 99 1.0× 32 0.4× 16 1.1k
Hengjun Chao United States 11 706 1.1× 737 1.3× 318 1.1× 50 0.5× 103 1.3× 17 994
Maureen Ward United States 16 793 1.3× 676 1.2× 404 1.4× 126 1.2× 198 2.6× 39 1.1k
Scott S. Case United States 9 532 0.8× 543 0.9× 165 0.6× 78 0.8× 41 0.5× 11 726
Conrado Soria United States 8 558 0.9× 519 0.9× 476 1.6× 100 1.0× 42 0.5× 8 913
Jennifer Potter United States 10 706 1.1× 483 0.8× 156 0.5× 100 1.0× 124 1.6× 15 955
Michael J. Kadan United States 11 440 0.7× 357 0.6× 410 1.4× 114 1.1× 74 1.0× 16 828
Babak Moghimi United States 14 493 0.8× 399 0.7× 474 1.6× 195 1.9× 120 1.6× 23 1.0k
Narda Whiting‐Theobald United States 14 332 0.5× 370 0.6× 321 1.1× 340 3.3× 109 1.4× 20 779

Countries citing papers authored by Anke Wahlers

Since Specialization
Citations

This map shows the geographic impact of Anke Wahlers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Wahlers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Wahlers more than expected).

Fields of papers citing papers by Anke Wahlers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Wahlers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Wahlers. The network helps show where Anke Wahlers may publish in the future.

Co-authorship network of co-authors of Anke Wahlers

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Wahlers. A scholar is included among the top collaborators of Anke Wahlers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Wahlers. Anke Wahlers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meyer, Johann, Mathias Rhein, Bernhard Schiedlmeier, et al.. (2007). Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA. Leukemia. 21(10). 2171–2180. 30 indexed citations
3.
Wahlers, Anke. (2004). Zur stationären Behandlung bei Tonsillektomie aus Sicht der Patienten. HNO. 52(2). 153–155.
4.
Kustikova, Olga, Anke Wahlers, Klaus Kühlcke, et al.. (2003). Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood. 102(12). 3934–3937. 139 indexed citations
5.
Wahlers, Anke, Peter F. Zipfel, Maike Schwieger, Wolfram Ostertag, & Christopher Baum. (2002). In Vivo Analysis of Retroviral Enhancer Mutations in Hematopoietic Cells: SP1/EGR1 and ETS/GATA Motifs Contribute to Long Terminal Repeat Specificity. Journal of Virology. 76(1). 303–312. 16 indexed citations
6.
Wahlers, Anke, Olga Kustikova, Peter F. Zipfel, et al.. (2002). Upstream Conserved Sequences of Mouse Leukemia Viruses Are Important for High Transgene Expression in Lymphoid and Hematopoietic Cells. Molecular Therapy. 6(3). 313–320. 13 indexed citations
7.
Li, Zhixiong, J. Düllmann, Bernd Schiedlmeier, et al.. (2002). Murine Leukemia Induced by Retroviral Gene Marking. Science. 296(5567). 497–497. 515 indexed citations breakdown →
8.
Fehse, Boris, Olga Kustikova, Z Li, et al.. (2002). A novel ‘sort-suicide’ fusion gene vector for T cell manipulation. Gene Therapy. 9(23). 1633–1638. 46 indexed citations
9.
Wahlers, Anke, Maike Schwieger, Z Li, et al.. (2001). Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells. Gene Therapy. 8(6). 477–486. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026